MADISON, Wis., July 17, 2017 /PRNewswire/ -- No Stomach For Cancer is pleased to announce the winners of the 2017 Grant for Gastric Cancer Innovation, Education, and Opportunity totaling $100,000. As part of the organization's global mission, it will fund significant research projects in the areas of immunotherapy, and blood biomarkers to predict early recurrence of stomach cancer.
The studies will be performed at the Peter MacCallum Cancer Centre in Australia and the Dana-Farber Cancer Institute in Boston. Located within the larger Victorian Comprehensive Cancer Centre (VCCC) in Melbourne, the Peter MacCallum Cancer Centre is one of Australia's leading research centers for cancer and oncology.
"As a global leader in stomach cancer advocacy, we will continue to support research that will deliver improved outcomes for patients," said Jon Florin, No Stomach For Cancer's Executive Director. "We are optimistic that these research programs will develop and grow into real world applications that improve earlier detection and a better quality of life for stomach cancer patients in the long term."
About No Stomach For Cancer
No Stomach For Cancer is a 501(c) (3) nonprofit organization whose mission is to support research and unite the caring power of people worldwide affected by stomach cancer. NSFC advances awareness and education about stomach cancer, including Hereditary Diffuse Gastric Cancer (HDGC), provides a support network for affected families and supports research for screening, early detection, treatment, and prevention of stomach cancer. Headquartered in Wisconsin, and serving patients across the globe, No Stomach For Cancer is a worldwide thought leader in stomach cancer awareness and education. Stomach Cancer is currently the third leading cause of cancer deaths worldwide with 1,000,000 new cases diagnosed each year. For more information, please visit www.nostomachforcancer.org/news
FOR MORE INFORMATION CONTACT:
No Stomach For Cancer
PO Box 46070, Madison WI 53744
SOURCE No Stomach For Cancer